Brian G Atwood - Net Worth and Insider Trading

Brian G Atwood Net Worth

The estimated net worth of Brian G Atwood is at least $42 Million dollars as of 2024-11-05. Brian G Atwood is the Director of Five Prime Therapeutics Inc and owns about 1,092,152 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $42 Million. Brian G Atwood is also the Director, 10% Owner of OpGen Inc and owns about 26 shares of OpGen Inc (OPGN) stock worth over $46. Details can be seen in Brian G Atwood's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian G Atwood has not made any transactions after 2015-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Brian G Atwood

To

Brian G Atwood Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian G Atwood owns 17 companies in total, including Atreca Inc (BCEL) , Clovis Oncology Inc (CLVSQ) , and PhaseRx Inc (PZRXQ) among others .

Click here to see the complete history of Brian G Atwood’s form 4 insider trades.

Insider Ownership Summary of Brian G Atwood

Ticker Comapny Transaction Date Type of Owner
BCEL Atreca Inc 2019-06-19 director
CLVSQ Clovis Oncology Inc 2016-06-09 director
PZRXQ PhaseRx Inc 2017-05-25 director & 10 percent owner
LIMIT LIMIT 2015-05-08 director
LIMIT LIMIT 2013-10-29 director & 10 percent owner
LIMIT LIMIT 2016-06-08 10 percent owner
LIMIT LIMIT 2015-06-24 10 percent owner
LIMIT LIMIT 2016-01-04 director
LIMIT LIMIT 2015-06-12 director
LIMIT LIMIT 2014-09-09 10 percent owner
LIMIT LIMIT 2014-11-18 10 percent owner
LIMIT LIMIT 2007-05-14 10 percent owner
LIMIT LIMIT 2006-05-09 10 percent owner
LIMIT LIMIT 2006-03-13 other: Former 10% Holder
LIMIT LIMIT 2021-01-07 director
LIMIT LIMIT 2021-10-05 director
LIMIT LIMIT 2014-11-18 10 percent owner

Brian G Atwood Latest Holdings Summary

Brian G Atwood currently owns a total of 2 stocks. Among these stocks, Brian G Atwood owns 1,092,152 shares of Five Prime Therapeutics Inc (FPRX) as of September 23, 2013, with a value of $42 Million and a weighting of 100%. Brian G Atwood also owns 26 shares of OpGen Inc (OPGN) as of May 8, 2015, with a value of $46 and a weighting of 0%.

Latest Holdings of Brian G Atwood

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FPRX Five Prime Therapeutics Inc 2013-09-23 1,092,152 38.00 41,501,776
OPGN OpGen Inc 2015-05-08 26 1.75 46

Holding Weightings of Brian G Atwood


Brian G Atwood Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian G Atwood has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the acquisition of 76,923 shares on September 23, 2013, which cost Brian G Atwood around $999,999.

According to the SEC Form 4 filings, Brian G Atwood has made a total of 0 transactions in OpGen Inc (OPGN) over the past 5 years. The most-recent trade in OpGen Inc is the acquisition of 4 shares on May 8, 2015, which cost Brian G Atwood around $2 Million.

Insider Trading History of Brian G Atwood

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian G Atwood Trading Performance

GuruFocus tracks the stock performance after each of Brian G Atwood's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian G Atwood is -7.87%. GuruFocus also compares Brian G Atwood's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian G Atwood within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian G Atwood's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian G Atwood

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.65 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.21 LIMIT LIMIT LIMIT LIMIT LIMIT

Brian G Atwood Ownership Network

Ownership Network List of Brian G Atwood

No Data

Ownership Network Relation of Brian G Atwood

Insider Network Chart

Brian G Atwood Owned Company Details

What does Atreca Inc do?

Who are the key executives at Atreca Inc?

Brian G Atwood is the director of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .

Atreca Inc (BCEL) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Atreca Inc Insider Transactions

No Available Data

Brian G Atwood Mailing Address

Above is the net worth, insider trading, and ownership report for Brian G Atwood. You might contact Brian G Atwood via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.